Accolade, Inc. (ACCD)

$9.34

+0.10 (+1.08%)
Rating:
Recommendation:
-
Symbol ACCD
Price $9.34
Beta 2.055
Volume Avg. 0.61M
Market Cap 712.009M
Shares () -
52 Week Range 6.33-17.005
1y Target Est -
DCF Unlevered ACCD DCF ->
DCF Levered ACCD LDCF ->
ROE -30.58% Strong Sell
ROA -16.57% Sell
Operating Margin -
Debt / Equity 71.69% Buy
P/E -4.99 Strong Sell
P/B 1.61 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ACCD news


Mr. Rajeev Singh
Healthcare
Health Information Services
NASDAQ Global Select

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.